Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed TherapiesMaximilian Merz, Uwe Platzbecker, Jan Sonntag et al.|Blood|2022Cited by 1